Notice2021-26361

Importer of Controlled Substances Application: Johnson Matthey Inc.

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
December 6, 2021

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Abstract

Johnson Matthey Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Full Text

<html>
<head>
<title>Federal Register, Volume 86 Issue 231 (Monday, December 6, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 231 (Monday, December 6, 2021)]
[Notices]
[Page 69070]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-26361]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-935]


Importer of Controlled Substances Application: Johnson Matthey 
Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Johnson Matthey Inc., has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before January 5, 2022. 
Such persons may also file a written request for a hearing on the 
application on or before January 5, 2022.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on November 2, 2021, Johnson Matthey Inc., 2003 Nolte 
Drive, West Deptford, New Jersey 08066-0727, applied to be registered 
as an importer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Coca Leaves.............................    9040  II
Thebaine................................    9333  II
Opium, raw..............................    9600  II
Noroxymorphone..........................    9668  II
Poppy Straw Concentrate.................    9670  II
Fentanyl................................    9801  II
------------------------------------------------------------------------

    The company plans to import Coca Leaves (9040), Opium raw (9600) 
and Poppy Straw Concentrate (9670) in order to bulk manufacture Active 
Pharmaceutical Ingredients (API) for distribution to its customers. The 
company plans to also import Thebaine (9333), Noroxymorphone (9668) and 
Fentanyl (9801) to use as analytical reference standards, both 
internally and to be sold to their customers to support testing of 
Johnson Matthey Inc.'s API's only.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of the Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-26361 Filed 12-3-21; 8:45 am]
BILLING CODE P


</pre></body>
</html>
Indexed from Federal Register on December 6, 2021.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.